Stock listing
ASX:ALC Alcidion Group Limited Share Price
Follow Alcidion Group Limited into a list and get an email when it puts out news.
Share price · ASX:ALC
$1.27 AUD +0.07 (+6.3%)
Close on Nov 20, 2026
- Day range
- $1.22 – $1.29 AUDNov 20, 2026
- Volume
- 78,049 sharesNov 20, 2026
- Market cap
- $171.4M AUDAt the close on Nov 20, 2026 · price × 135.0M shares outstanding
- 52-week range
- $0.83 – $1.45 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $20,363 AUDMedian day 5,871 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:ALC · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.27 | +0.075 | +6.3% | $1.215 | $1.285 | $1.215 | 78,049 | |
| $1.195 | -0.055 | -4.4% | $1.20 | $1.225 | $1.195 | 61,043 | |
| $1.25 | 0.00 | 0.0% | $1.30 | $1.30 | $1.19 | 47,434 | |
| $1.25 | +0.10 | +8.7% | $1.15 | $1.25 | $1.15 | 46,979 | |
| $1.15 | +0.10 | +9.5% | $1.10 | $1.20 | $1.10 | 17,246 | |
| $1.05 | -0.10 | -8.7% | $1.15 | $1.15 | $1.05 | 17,288 | |
| $1.15 | +0.10 | +9.5% | $1.10 | $1.15 | $1.10 | 7,195 | |
| $1.05 | 0.00 | 0.0% | $1.075 | $1.10 | $1.05 | 1,378 | |
| $1.05 | 0.00 | 0.0% | $1.10 | $1.10 | $1.05 | 427,341 | |
| $1.05 | -0.10 | -8.7% | $1.15 | $1.15 | $1.05 | 353 | |
| $1.15 | +0.10 | +9.5% | $1.05 | $1.15 | $1.05 | 4,274 | |
| $1.05 | -0.05 | -4.5% | $1.10 | $1.10 | $1.05 | 8,297 | |
| $1.10 | +0.05 | +4.8% | $1.10 | $1.10 | $1.075 | 1,836 | |
| $1.05 | -0.05 | -4.5% | $1.10 | $1.10 | $1.05 | 2,984 | |
| $1.10 | -0.05 | -4.3% | $1.20 | $1.20 | $1.075 | 46,575 | |
| $1.15 | 0.00 | 0.0% | $1.15 | $1.20 | $1.15 | 17,121 | |
| $1.15 | +0.05 | +4.5% | $1.15 | $1.15 | $1.10 | 9,009 | |
| $1.10 | +0.10 | +10.0% | $1.05 | $1.10 | $1.00 | 29,289 | |
| $1.00 | 0.00 | 0.0% | $0.99 | $1.05 | $0.97 | 13,342 | |
| $1.00 | +0.04 | +4.2% | $0.95 | $1.00 | $0.95 | 5,559 | |
| $0.96 | -0.01 | -1.0% | $0.97 | $0.99 | $0.95 | 7,607 | |
| $0.97 | +0.01 | +1.0% | $0.97 | $0.97 | $0.955 | 536 | |
| $0.96 | +0.01 | +1.1% | $0.95 | $0.97 | $0.94 | 6,121 | |
| $0.95 | -0.03 | -3.1% | $0.99 | $0.99 | $0.95 | 15,352 | |
| $0.98 | -0.01 | -1.0% | $0.98 | $1.00 | $0.97 | 982 | |
| $0.99 | +0.01 | +1.0% | $0.99 | $1.00 | $0.98 | 2,881 | |
| $0.98 | -0.02 | -2.0% | $0.98 | $0.98 | $0.97 | 3,678 | |
| $1.00 | 0.00 | 0.0% | $1.00 | $1.00 | $0.98 | 5,050 | |
| $1.00 | +0.01 | +1.0% | $0.99 | $1.00 | $0.98 | 7,959 | |
| $0.99 | -0.01 | -1.0% | $0.99 | $1.025 | $0.98 | 17,700 | |
| $1.00 | -0.05 | -4.8% | $1.05 | $1.05 | $0.99 | 17,020 | |
| $1.05 | +0.05 | +5.0% | $1.05 | $1.05 | $1.00 | 1,795 | |
| $1.00 | 0.00 | 0.0% | $1.00 | $1.05 | $1.00 | 11,892 | |
| $1.00 | 0.00 | 0.0% | $1.00 | $1.05 | $1.00 | 2,775 | |
| $1.00 | -0.05 | -4.8% | $1.00 | $1.05 | $1.00 | 3,178 | |
| $1.05 | -0.05 | -4.5% | $1.05 | $1.10 | $1.00 | 19,615 | |
| $1.10 | +0.05 | +4.8% | $1.05 | $1.10 | $1.00 | 21,501 | |
| $1.05 | 0.00 | 0.0% | $1.00 | $1.05 | $1.00 | 295 | |
| $1.05 | 0.00 | 0.0% | $1.05 | $1.05 | $1.00 | 5,622 | |
| $1.05 | +0.025 | +2.4% | $1.025 | $1.05 | $1.00 | 2,197 | |
| $1.025 | +0.025 | +2.5% | $1.00 | $1.05 | $1.00 | 1,331 | |
| $1.00 | 0.00 | 0.0% | $1.025 | $1.05 | $1.00 | 1,132 | |
| $1.00 | 0.00 | 0.0% | $1.00 | $1.05 | $1.00 | 1,444 | |
| $1.00 | +0.01 | +1.0% | $1.00 | $1.05 | $0.99 | 5,566 | |
| $0.99 | -0.01 | -1.0% | $1.00 | $1.025 | $0.99 | 3,225 | |
| $1.00 | 0.00 | 0.0% | $1.05 | $1.05 | $1.00 | 4,692 | |
| $1.00 | 0.00 | 0.0% | $1.05 | $1.05 | $1.00 | 934 | |
| $1.00 | 0.00 | 0.0% | $1.00 | $1.00 | $0.99 | 10,910 | |
| $1.00 | -0.05 | -4.8% | $1.00 | $1.00 | $0.99 | 4,366 | |
| $1.05 | 0.00 | 0.0% | $1.00 | $1.05 | $0.99 | 5,501 | |
| $1.05 | +0.05 | +5.0% | $1.00 | $1.05 | $1.00 | 6,644 | |
| $1.00 | 0.00 | 0.0% | $1.00 | $1.00 | $1.00 | 891 | |
| $1.00 | -0.05 | -4.8% | $1.025 | $1.05 | $1.00 | 903 | |
| $1.05 | 0.00 | 0.0% | $1.00 | $1.05 | $1.00 | 3,445 | |
| $1.05 | +0.075 | +7.7% | $0.98 | $1.05 | $0.98 | 22,346 | |
| $0.975 | +0.005 | +0.5% | $0.97 | $0.99 | $0.97 | 8,192 | |
| $0.97 | 0.00 | 0.0% | $0.97 | $0.97 | $0.95 | 4,188 | |
| $0.97 | 0.00 | 0.0% | $0.97 | $0.97 | $0.93 | 15,022 | |
| $0.97 | 0.00 | 0.0% | $0.98 | $0.98 | $0.95 | 3,835 | |
| $0.97 | +0.01 | +1.0% | $0.97 | $0.97 | $0.95 | 4,502 | |
| $0.96 | +0.03 | +3.2% | $0.94 | $0.96 | $0.93 | 17,730 | |
| $0.93 | -0.03 | -3.1% | $0.96 | $0.97 | $0.93 | 13,863 | |
| $0.96 | +0.02 | +2.1% | $0.96 | $0.97 | $0.945 | 4,219 | |
| $0.94 | +0.03 | +3.3% | $0.93 | $0.95 | $0.91 | 21,251 | |
| $0.91 | -0.04 | -4.2% | $0.95 | $0.95 | $0.91 | 7,796 | |
| $0.95 | +0.04 | +4.4% | $0.92 | $0.95 | $0.895 | 83,370 |
Splits
1 split · ASX:ALC · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- ASX:ALC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 22, 2026
Update - Notification of buy-back - ALC
Latest deck · Nov 12, 2026
Shareholder Meeting (November 2026)
Shareholder meeting · 35 slides
Latest news
Update - Consolidation/Split - ALC
Nov 12, 2026
Closed $1.15 (+9.5%) on Nov 13, 2026
Consolidation of Capital Approved
Nov 12, 2026
Closed $1.15 (+9.5%) on Nov 13, 2026
Results of 2026 Annual General Meeting
Nov 12, 2026
Closed $1.15 (+9.5%) on Nov 13, 2026
2026 Annual General Meeting Chair Address & Presentation
Nov 11, 2026
Closed $1.05 (-8.7%) on Nov 12, 2026
Trading Update
Oct 28, 2026
Closed $1.15 (0.0%) on Oct 29, 2026
Notification of buy-back - ALC
Oct 26, 2026
Closed $1.10 (+10.0%) on Oct 27, 2026
On-Market Share Buy-Back Announcement
Oct 26, 2026
Closed $1.10 (+10.0%) on Oct 27, 2026
Notification of cessation of securities - ALC
Oct 15, 2026
Closed $0.98 (-1.0%) on Oct 16, 2026
Consolidation/Split - ALC
Oct 8, 2026
Closed $0.99 (-1.0%) on Oct 9, 2026
Alcidion Group Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 43 in the last 12 months · 249 in all · newest Nov 22, 2026 · oldest 2016
- Decks
- 54 decks · latest Nov 12, 2026
Valuation
P/E 75.0× against a median of 17.7×: the highest of 8 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $151.6M AUD
- P/E
- 75.0×
- EV/sales
- 2.9×
- EV/EBITDA
- 20.1×
- Price/book
- 1.9×
- Gross margin
- 17.8%
- Operating margin
- 4.9%
- Net margin
- 4.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Alcidion Group Limited · ASX:ALC | US$113.5M | US$100.4M | 75.0× | 2.9× | 20.1× | 1.9× | 4.4% | 0.0× | n/a |
| Nordhealth AS · OSL:NORDH | US$121.9M | US$108.1M | n/a | 1.9× | 45.6× | 2.0× | −29.9% | 0.0× | n/a |
| CHC Healthcare Group · TWSE:4164 | US$121.1M | US$251.3M | 17.7× | 1.8× | 7.3× | 0.5× | 4.9% | 0.8× | n/a |
| Ekachai Medical Care Public Company Limited · SET:EKH | US$119.7M | US$99.99M | 15.0× | 2.6× | 8.3× | 1.8× | 20.9% | 0.0× | n/a |
| Honliv Healthcare Management Group Co Ltd · HKEX:9906 | US$119.4M | US$100.2M | n/a | n/a | n/a | 1.7× | n/a | 0.3× | n/a |
| GPT Healthcare Limited · NSE:GPTHEALTH | US$118.6M | US$118.6M | 23.3× | 2.2× | 12.1× | 4.1× | 9.6% | 0.0× | n/a |
| Icon Group Ltd · TASE:ICON | US$117.7M | US$193.0M | 7.8× | 0.4× | 6.5× | 1.4× | 2.9% | 0.9× | n/a |
| Hydreight Technologies Inc · TSXV:NURS | US$114.2M | US$106.4M | 24.3× | 1.9× | 17.7× | 4.2× | 8.6% | 0.2× | 0.95 |
| Kindstar Globalgene Technology, Inc. · HKEX:9960 | US$111.6M | −US$99.19M | n/a | −0.7× | n/a | 0.3× | −6.3% | 0.1× | n/a |
| Auna SA · NYSE:AUNA | US$110.3M | US$1.05B | 24.8× | 0.8× | 4.3× | 0.2× | 0.3% | 2.0× | 1.03 |
| BenQ BM Holding Cayman Corp. · HKEX:2581 | US$110.2M | US$43.03M | 7.7× | 0.1× | 0.8× | 0.3× | 3.5% | 0.1× | n/a |
| Median of the others | US$118.2M | US$107.3M | 17.7× | 1.8× | 7.8× | 1.6× | 3.5% | 0.2× | 0.99 |
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.15 AUD · Analysts' mean
- EPS, year to Jun 2027
- 0.002 · 4 analysts
- Revenue, year to Jun 2027
- 55.65M · 4 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Kate Quirke | Group Managing Director/Chief Executive Officer |
| Matthew Gepp | Chief Financial Officer |
| Julia Stevens | Chief Operating Officer |
| Amanda James | Chief People Officer |
| Andy Smallman | Director of Strategic Business Development |
| Kaye Hocking | Chief Product Officer |
| Nick White | Chief Marketing Officer |
| Paul Deffley | Chief Medical Officer/UK Managing Director |
| Sean Walker | Chief Technology Officer |
| Tracy McClelland | Chief Clinical Information Officer |
Board
| Director | Role |
|---|---|
| Rebecca Wilson | CHAIR |
| Andrew Way | Non-Executive Director |
| Daniel Sharp | Non-Executive Director |
| Will Smart | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2025 | Dec 3, 2025 | 0.0% |
| Q4 2025 | Aug 27, 2025 | 0.0% |
| Quarter to Mar 31, 2025 | May 28, 2025 | +7.4% |
| Q2 2025 | Feb 26, 2025 | +3.3% |
| Quarter to Sep 30, 2024 | Nov 27, 2024 | −1.5% |
| Q4 2024 | Aug 29, 2024 | −2.7% |
| Quarter to Mar 31, 2024 | May 29, 2024 | −1.8% |
| Q2 2024 | Feb 27, 2024 | −4.3% |
| Q2 2023 | Feb 23, 2023 · After close | 0.0% |
| Q4 2022 | Aug 29, 2022 · After close | +3.3% |
All 13 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2022 | Feb 22, 2022 · After close | 0.0% |
| Q4 2021 | Aug 23, 2021 · After close | 0.0% |
| Q2 2021 | Feb 24, 2021 · After close | +8.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (November 2026) | Shareholder meeting | 35 slides | Nov 12, 2026 |
| FY2026 Earnings Presentation | Earnings | 34 slides | Aug 19, 2026 |
| Non-Deal Roadshow (June 2026) | Roadshow | 36 slides | Jun 29, 2026 |
| H1 2026 Earnings Presentation | Earnings | 36 slides | Feb 26, 2026 |
| Shareholder Meeting (October 2025) | Shareholder meeting | 33 slides | Oct 16, 2025 |
| Investor Presentation (September 2025) | Investor deck | 40 slides | Sep 15, 2025 |
| FY2025 Earnings Presentation | Earnings | 28 slides | Aug 28, 2025 |
| Investor Presentation (March 2025) | Investor deck | 37 slides | Mar 12, 2025 |
| Coffee Microcaps Results Webinar March 2025 | Conference | 19 slides | Mar 7, 2025 |
| H1 2025 Earnings Presentation | Earnings | 25 slides | Feb 27, 2025 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (October 2024) | Shareholder meeting | 42 slides | Oct 23, 2024 |
| FY2024 Earnings Presentation | Earnings | 28 slides | Aug 29, 2024 |
| H1 FY2024 Earnings Presentation | Earnings | 29 slides | Feb 28, 2024 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 14 slides | Nov 20, 2023 |
| Investor Presentation (August 2023) | Investor deck | 31 slides | Aug 24, 2023 |
| Canaccord Genuity 43rd Annual Growth Conference 2023 | Conference | 20 slides | Aug 10, 2023 |
| H1 FY2023 Earnings Presentation | Earnings | 28 slides | Feb 24, 2023 |
| Shareholder Meeting (November 2022) | Shareholder meeting | 15 slides | Nov 30, 2022 |
| FY2022 Earnings Presentation | Earnings | 30 slides | Sep 12, 2022 |
| Investor Presentation (August 2022) | Investor deck | 13 slides | Aug 30, 2022 |
| H1 2022 Earnings Presentation | Earnings | 21 slides | Feb 23, 2022 |
| Q2 FY22 Earnings Presentation | Earnings | 6 slides | Jan 27, 2022 |
| Investor Presentation (December 2021) | Investor deck | 43 slides | Dec 7, 2021 |
| Shareholder Meeting (November 2021) | Shareholder meeting | 13 slides | Nov 17, 2021 |
| Q1 FY22 Earnings Presentation | Earnings | 5 slides | Oct 26, 2021 |
| FY2021 Earnings Presentation | Earnings | 31 slides | Sep 15, 2021 |
| FY2021 Earnings Presentation | Earnings | 16 slides | Aug 24, 2021 |
| Investor Presentation (June 2021) | Investor deck | 15 slides | Jun 30, 2021 |
| Investor Presentation (April 2021) | Investor deck | 17 slides | Apr 15, 2021 |
| H1 FY2021 Earnings Presentation | Earnings | 9 slides | Feb 25, 2021 |
| Shareholder Meeting (November 2020) | Shareholder meeting | 11 slides | Nov 19, 2020 |
| FY2020 Earnings Presentation | Earnings | 20 slides | Sep 9, 2020 |
| Non-Deal Roadshow (February 2020) | Roadshow | 27 slides | Feb 11, 2020 |
| Shareholder Meeting (November 2019) | Shareholder meeting | 17 slides | Nov 14, 2019 |
| Investor Presentation (November 2019) | Investor deck | 12 slides | Nov 5, 2019 |
| Investor Presentation (October 2019) | Investor deck | 32 slides | Oct 14, 2019 |
| Investor Presentation (May 2019) | Investor deck | 16 slides | May 1, 2019 |
| Investor Presentation (March 2019) | Investor deck | 15 slides | Mar 18, 2019 |
| Investor Presentation (October 2018) | Investor deck | 18 slides | Oct 15, 2018 |
| Merger or Acquisition (May 2018) | Merger or acquisition | 24 slides | May 2, 2018 |
| Shareholder Meeting (November 2017) | Shareholder meeting | 9 slides | Nov 24, 2017 |
| Investor Presentation (May 2017) | Investor deck | 19 slides | May 29, 2017 |
| TechKnow Invest Roadshow 2017 | Conference | 24 slides | Mar 15, 2017 |
| Shareholder Meeting (November 2016) | Shareholder meeting | 24 slides | Nov 29, 2016 |
| TechKnow Invest Roadshow 2016 | Conference | 22 slides | Oct 6, 2016 |
| Investor Presentation (August 2016) | Investor deck | 57 slides | Aug 31, 2016 |
| Health Informatics (July 2016) | Conference | 17 slides | Jul 26, 2016 |
| Investor Presentation (May 2016) | Investor deck | 17 slides | Apr 29, 2016 |
| Investor Presentation (February 2016) | Investor deck | 38 slides | Feb 26, 2016 |
| Miya ED webinar (October 2015) | Conference | 11 slides | October 2015 |
This page holds 50 of 54 decks. Open Decks
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51.6M | 40.8M | 37.1M | 40.4M | 34.4M | 25.9M | 18.6M | 16.9M | 4.18M | 3.46M |
| Cost of revenue | 42.5M | 4.80M | 5.14M | 39.1M | 31.1M | 22.4M | 18.2M | 11.0M | 2.77M | 1.18M |
| Gross profit | 9.16M | 36.0M | 31.9M | 1.25M | 3.29M | 3.52M | 401.2K | 5.91M | 1.40M | 2.28M |
| Selling, general and administrative | 28.5M | 1.09M | 28.3M | 28.3M | 22.4M | 17.4M | 6.27M | 13.8M | 3.95M | 3.94M |
| Operating income | 2.55M | 7.81M | -7.65M | -4.73M | -1.73M | -174.0K | -2.32M | -125.5K | -2.21M | -2.14M |
| Depreciation and amortization | 5.00M | 4.59M | 4.10M | 3.19M | 2.26M | 457.0K | 247.4K | 65.9K | 47.2K | 55.3K |
| EBITDA | 7.55M | 12.4M | -3.55M | -1.54M | 528.0K | 283.0K | -2.07M | -59.6K | -2.16M | -2.09M |
| Interest expense | 57.0K | 81.0K | 103.0K | 125.0K | 68.0K | 3.00K | 74.4K | 15.6K | 73.7K | 0 |
| Income before tax | 1.32M | 320.0K | -8.70M | -4.74M | -3.91M | -934.0K | -4.02M | -109.9K | -2.14M | -2.04M |
| Income tax | -968.0K | 1.33M | -282.0K | -1.12M | 504.0K | 1.31M | -941.6K | -25.8K | -45.9K | 21.9K |
| Net income | 2.29M | 1.65M | -8.42M | -3.62M | -4.41M | -2.24M | -3.08M | -84.2K | -2.09M | -2.06M |
| Earnings per share, basic | 0.00 | 0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 20.6M | 17.7M | 11.8M | 14.6M | 17.3M | 25.0M | 15.9M | 3.17M | 2.89M | 5.33M |
| Short-term investments | 73.5K | |||||||||
| Receivables | 6.06M | 3.68M | 5.21M | 4.74M | 7.25M | 4.11M | 3.83M | 3.42M | 499.5K | 249.5K |
| Inventory | 1 | 1 | 1 | |||||||
| Current assets | 29.7M | 23.7M | 18.5M | 21.0M | 26.3M | 30.3M | 20.2M | 6.87M | 4.48M | 6.64M |
| Property, plant and equipment | 1.59M | 1.97M | 2.87M | 3.27M | 549.0K | 549.9K | 157.6K | 90.0K | 97.8K | |
| Goodwill | 68.7M | 67.8M | 67.8M | 67.8M | 67.8M | 25.5M | 15.4M | 15.4M | 771.1K | |
| Total assets | 121.9M | 115.6M | 114.5M | 120.7M | 128.4M | 58.4M | 39.4M | 24.9M | 5.83M | 6.83M |
| Accounts payable | 2.26M | 616.0K | 305.0K | 2.13M | 1.65M | 766.0K | 991.3K | 509.2K | 201.4K | 99.6K |
| Current liabilities | 24.4M | 20.9M | 19.2M | 21.3M | 24.4M | 13.0M | 9.41M | 11.5M | 2.39M | 1.38M |
| Total debt | 814.0K | 1.41M | 1.70M | 2.15M | 2.48M | 181.0K | 315.9K | |||
| Total liabilities | 31.0M | 27.8M | 27.5M | 30.5M | 34.4M | 13.2M | 9.70M | 11.6M | 2.50M | 1.41M |
| Shareholders' equity | 90.9M | 87.8M | 86.9M | 90.2M | 94.0M | 45.2M | 29.7M | 13.2M | 3.33M | 5.42M |
| Shares outstanding | 1.34B | 1.34B | 1.32B | 1.27B | 1.16B | 1.02B | 953.1M | 821.3M | 607.8M | 604.2M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 6.85M | 5.76M | -7.13M | 169.0K | 996.0K | 1.54M | -2.02M | 1.99M | -1.83M | -519.4K |
| Capital spending | -226.0K | -125.0K | -53.0K | -454.0K | -311.0K | -313.0K | -123.8K | -264.8K | -23.9K | -14.6K |
| Free cash flow | 6.62M | 5.64M | -7.18M | -285.0K | 685.0K | 1.23M | -2.14M | 1.73M | -1.85M | -534.0K |
| Cash from investing | -1.70M | -125.0K | -53.0K | -3.14M | -59.7M | -9.84M | -362.0K | -1.74M | -615.6K | -14.6K |
| Cash from financing | -800.0K | -764.0K | 4.34M | -616.0K | 51.3M | 17.2M | 15.2M | 31.4K | 31.4K | 219.9K |
| Share buybacks | 0 | -399.0K | 0 | 51.9M | 17.5M | 15.4M | 0 | 225.0K | ||
| Change in cash | 2.94M | 5.90M | -2.84M | -2.70M | -7.69M | 9.08M | 12.8M | 281.5K | -2.44M | -314.1K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Update - Notification of buy-back - ALC | Nov 22, 2026 | Treasury share status | ASX |
| Update - Notification of buy-back - ALC | Nov 19, 2026 | Treasury share status | ASX |
| Update - Notification of buy-back - ALC | Nov 18, 2026 | Notification letter | ASX |
| Update - Notification of buy-back - ALC | Nov 17, 2026 | Treasury share status | ASX |
| Update - Notification of buy-back - ALC | Nov 16, 2026 | Treasury share status | ASX |
| Update - Notification of buy-back - ALC | Nov 15, 2026 | Treasury share status | ASX |
| Update - Consolidation/Split - ALC | Nov 12, 2026 | Other filings | ASX |
| Consolidation of Capital Approved | Nov 12, 2026 | Other filings | ASX |
| Results of 2026 Annual General Meeting | Nov 12, 2026 | Meeting outcome | ASX |
| 2026 Annual General Meeting Chair Address & Presentation | Nov 11, 2026 | Meeting notice | ASX |
Show 200 filings
This page holds 200 of 243 filings. Open Filings
Cap table
Built by 6ix from Alcidion Group Limited’s releases · as of Nov 15, 2026
- Common shares
- 134,980,515
- Fully diluted
- 134,980,515
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 134,980,515 | Nov 15, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 15, 2026 | 134,980,515 |
| Nov 15, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Amanda James | Chief People Officer · Since at least Nov 4, 2026 |
| Andrew Way | Non-Executive Director · Since at least Nov 5, 2026 |
| Andy Smallman | Director of Strategic Business Development · Since at least Nov 4, 2026 |
| Daniel Sharp | Non-Executive Director · Since at least Nov 5, 2026 |
| Julia Stevens | Chief Operating Officer · Since at least Nov 4, 2026 |
| Kate Quirke | Group Managing Director/Chief Executive Officer · Since at least Nov 4, 2026 |
| Kaye Hocking | Chief Product Officer · Since at least Nov 4, 2026 |
| Matthew Gepp | Chief Financial Officer · Since at least Nov 4, 2026 |
| Nick White | Chief Marketing Officer · Since at least Nov 4, 2026 |
| Paul Deffley | Chief Medical Officer/UK Managing Director · Since at least Nov 4, 2026 |
All 14 people
| Person | Seat |
|---|---|
| Rebecca Wilson | CHAIR · Since at least Nov 5, 2026 |
| Sean Walker | Chief Technology Officer · Since at least Nov 4, 2026 |
| Tracy McClelland | Chief Clinical Information Officer · Since at least Nov 4, 2026 |
| Will Smart | Non-Executive Director · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Alcidion Group Limited.